Trial Information

Summary: Bipolar Disorder: Research Study Testing the Effectiveness of an Investigational Medication

Official Title: A Multicenter, Randomized, Parallel-group, Double-blind, Phase III Comparison of the Efficacy and Safety of Quetiapine fumarate (oral tablets 400 mg to 800 mg daily in divided doses) to Placebo When Used as Adjunct to Mood Stabilizers (Lithium or Valproate) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients - D1447C00126

Do you feel depressed, hopeless?
Do you have difficulty concentrating?
Have you lost interest in activities you used to enjoy?
Has your appetite changed?
Do you have difficulty sleeping or have a decreased need for sleep?
Are there times when you feel irritable and angry, out of control?
Do you impulsively buy things?
Are you often creating or ending relationships?
Talk too much?

If so, you may be suffering with Bipolar Disorder. You may be eligible to participate in a research study testing and investigational medication and receive medication at no cost. Enroll Today!

Patient Inclusion Criteria

• Male or female, at least 18 years old
• A current manic, depressed, or mixed episode by DSM-IV criteria

Study Start Date 4/28/2005

Target Number Of Subjects 12

If you would like to learn more about participating in this study, please send an e-mail message using the form below.